However, these concerns have not been confirmed in human studies
Wegovy (semaglutide) is a glucagon-like peptide-1 (GLP-1) receptor agonist for chronic weight management, along with a reduced calorie diet and increased physical activity, for people with an initial body mass index (BMI) of: 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia)
A provider who knows your history can make these adjustments intelligently
Peptide therapy in Carson City offers a scientifically-backed solution to help you achieve your weight loss goals
Brand-name Ozempic imports from Canada are well-established
Focus on lean meats, fish, eggs, Greek yogurt, legumes, and protein supplements if needed